Abstract
In many patients, topical hemostatics, antifibrinolytics, and coagulation factor stimulators can eliminate or markedly reduce the need for blood product transfusions—with their attendant hazards and costs. Desmopressin has the added advantage of minimal side effects and a broad range of applications in both hemostatically normal and impaired patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
